Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
RVMDWRevolution Medicines, Inc.
| Figure | RVMDWRevolution Medicines, Inc.FY2025 · Dec |
|---|---|
| Revenue | $0.00 |
| Revenue, yoy | — |
| Net income | $1.13B |
| Net income, yoy | −88.5% |
| Net margin | — |
| Free cash flow | $913.73M |
| FCF margin | — |
| EPS, diluted | $5.95 |
Add another company.
Annual · FY2021–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed